Cargando…

Efficacy of heart failure reversal treatment in patients with low ejection fraction

BACKGROUND: Heart failure reversal therapy (HFRT) is designed to enhance cardiorespiratory fitness of chronic heart failure (CHF) patients. OBJECTIVE(S): The present study was designed to evaluate efficacy of HFRT that uses herbal procedure (panchakarma) and allied therapies, in CHF patients with lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Rohit, Sane, Rahul, Mandole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314236/
https://www.ncbi.nlm.nih.gov/pubmed/30287144
http://dx.doi.org/10.1016/j.jaim.2017.08.004
_version_ 1783384084573061120
author Rohit, Sane
Rahul, Mandole
author_facet Rohit, Sane
Rahul, Mandole
author_sort Rohit, Sane
collection PubMed
description BACKGROUND: Heart failure reversal therapy (HFRT) is designed to enhance cardiorespiratory fitness of chronic heart failure (CHF) patients. OBJECTIVE(S): The present study was designed to evaluate efficacy of HFRT that uses herbal procedure (panchakarma) and allied therapies, in CHF patients with low ejection fraction. METHODS: This efficacy study was conducted in CHF patients (aged: 25–65 years, ejection fraction (EF) 10–30%) wherein HFRT (60–75 min) consisting of snehana (external oleation), swedana (passive heat therapy), hrudaydhara (concoction dripping treatment) and basti (enema) was administered twice daily for 7 days. During this therapy and next 30 days, patients followed the study dinarcharya and were prescribed ARJ kadha in addition to their conventional treatment. The primary endpoint of this study was evaluation of maximum aerobic capacity uptake (MAC) as assessed by 6 min walk distance (6MWD) using Cahalins equation from baseline, at the end of 7 day treatment, follow-up after 30 days and 90 days. EF was assessed by 2D Echo at baseline and after 30 days of follow-up. RESULTS: Fifty-two CHF patients with 10–30% EF (mean [SD] age: 58.8 [10.8], 85% men) were enrolled in the study. There was a 100% compliance to study therapy. A significant improvement was observed in MAC levels (7.11%, p = 0.029), at the end of 7 day therapy as compared to baseline. This improvement was maintained at two follow-up visits. Moreover ejection fraction was observed to be increased by 6.38%, p = 0.012 as compared to baseline at day 7 of the therapy. CONCLUSION: This 90 day follow up study highlights the benefit of HFRT, as a part of maintenance treatment for CHF patients with reduced ejection fraction.
format Online
Article
Text
id pubmed-6314236
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-63142362019-01-07 Efficacy of heart failure reversal treatment in patients with low ejection fraction Rohit, Sane Rahul, Mandole J Ayurveda Integr Med Original Research Articles - Clinical BACKGROUND: Heart failure reversal therapy (HFRT) is designed to enhance cardiorespiratory fitness of chronic heart failure (CHF) patients. OBJECTIVE(S): The present study was designed to evaluate efficacy of HFRT that uses herbal procedure (panchakarma) and allied therapies, in CHF patients with low ejection fraction. METHODS: This efficacy study was conducted in CHF patients (aged: 25–65 years, ejection fraction (EF) 10–30%) wherein HFRT (60–75 min) consisting of snehana (external oleation), swedana (passive heat therapy), hrudaydhara (concoction dripping treatment) and basti (enema) was administered twice daily for 7 days. During this therapy and next 30 days, patients followed the study dinarcharya and were prescribed ARJ kadha in addition to their conventional treatment. The primary endpoint of this study was evaluation of maximum aerobic capacity uptake (MAC) as assessed by 6 min walk distance (6MWD) using Cahalins equation from baseline, at the end of 7 day treatment, follow-up after 30 days and 90 days. EF was assessed by 2D Echo at baseline and after 30 days of follow-up. RESULTS: Fifty-two CHF patients with 10–30% EF (mean [SD] age: 58.8 [10.8], 85% men) were enrolled in the study. There was a 100% compliance to study therapy. A significant improvement was observed in MAC levels (7.11%, p = 0.029), at the end of 7 day therapy as compared to baseline. This improvement was maintained at two follow-up visits. Moreover ejection fraction was observed to be increased by 6.38%, p = 0.012 as compared to baseline at day 7 of the therapy. CONCLUSION: This 90 day follow up study highlights the benefit of HFRT, as a part of maintenance treatment for CHF patients with reduced ejection fraction. Elsevier 2018 2018-10-01 /pmc/articles/PMC6314236/ /pubmed/30287144 http://dx.doi.org/10.1016/j.jaim.2017.08.004 Text en © 2017 Transdisciplinary University, Bangalore and World Ayurveda Foundation. Publishing Services by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research Articles - Clinical
Rohit, Sane
Rahul, Mandole
Efficacy of heart failure reversal treatment in patients with low ejection fraction
title Efficacy of heart failure reversal treatment in patients with low ejection fraction
title_full Efficacy of heart failure reversal treatment in patients with low ejection fraction
title_fullStr Efficacy of heart failure reversal treatment in patients with low ejection fraction
title_full_unstemmed Efficacy of heart failure reversal treatment in patients with low ejection fraction
title_short Efficacy of heart failure reversal treatment in patients with low ejection fraction
title_sort efficacy of heart failure reversal treatment in patients with low ejection fraction
topic Original Research Articles - Clinical
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314236/
https://www.ncbi.nlm.nih.gov/pubmed/30287144
http://dx.doi.org/10.1016/j.jaim.2017.08.004
work_keys_str_mv AT rohitsane efficacyofheartfailurereversaltreatmentinpatientswithlowejectionfraction
AT rahulmandole efficacyofheartfailurereversaltreatmentinpatientswithlowejectionfraction